UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
-
-
-
-
-
-
UBS on why it's still not ready to push the buy button on pharma stocks
-
-
-
-
-
-
-
Abbott Labs (ABT) PT Raised to $99 at UBS
-
-
-
-
-
-
-
UBS Remains Neutral on Abbott (ABT) Following 4Q Earnings and Conference Call
-
-
-
-
-
-
-
UBS Lifts Target on Abbott Labs (ABT) Ahead of Split
-
-
-
-
-
-
-
UBS Reiterates a 'Buy' on Abbott Labs (ABT); Valuing the Break-up
-
-
-
-
-
-
-
Notable Analyst Rating Changes 11/18: NTAP, ATI, STP, PERY Upgraded; ALU, ABT, F, CMG Downgraded
-
-
-
-
-
-
-
Johnson & Johnson's (JNJ) Wins $1.67B Patent Verdict Versus Abbott Laboratories (ABT)
-
169,655 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

